28 Stocks Moving In Monday's Pre-Market Session

Gainers

• Transenterix Inc TRXC rose 100 percent to $2.92 in pre-market trading following FDA 510(k) clearance for its Senhance System.
• Cardiovascular Systems Inc CSII rose 20.7 percent to $33.50 in pre-market trading after dropping 1.80 percent on Friday.
• Exelixis, Inc. EXEL gained 19.1 percent to $29.50 after the company disclosed that its Phase 3 CELESTIAL trial met its primary endpoint.
• VirnetX Holding Corporation VHC shares rose 17.9 percent to $8.25 in the pre-market trading session after declining 14.63 percent on Friday.
• Leading Brands, Inc (USA) LBIX shares rose 15 percent to $2.61 in pre-market trading after climbing 68.15 percent on Friday.
• Aegean Marine Petroleum Network Inc. ANW rose 13.64 percent to $5 in pre-market trading after falling 1.12 percent on Friday.
• 22nd Century Group Inc XXII rose 12.9 percent to $3.16 in pre-market trading after falling 3.11 percent on Friday.
• Aratana Therapeutics Inc PETX rose 12 percent to $7.00 in pre-market trading after the company announced plans to launch ENTYCE in the United States.
• Helios and Matheson Analytics Inc HMNY shares rose 6.1 percent to $21.65 in pre-market trading after slipping 0.49 percent on Friday.
• Ehi Car Services Ltd (ADR) EHIC shares rose 5.2 percent to $11.42 in pre-market trading after dropping 0.82 percent on Friday.
• Hudbay Minerals Inc HBM rose 5.1 percent to $8.35 in the pre-market trading session after slipping 1.24 percent on Friday.
• Nationstar Mortgage Holdings Inc NSM rose 5.1 percent to $20.62 after gaining 6.17 percent on Friday.
• CF Industries Holdings, Inc. CF rose 5.1 percent to $38.66 in pre-market trading after gaining 2.68 percent on Friday.
• Riverview Bancorp, Inc. RVSB shares rose 4.8 percent to $9.23 in pre-market trading.
• Yext Inc YEXT rose 4.4 percent to $13 in pre-market trading. KeyBanc upgraded Yext from Sector Weight to Overweight.
• Fennec Pharmaceuticals Inc FENC shares rose 3.8 percent to $12.50 in the pre-market trading session after the company reported that its Phase 3 SIOPEL study met its primary endpoint.
• Groupon Inc GRPN shares rose 3.7 percent to $4.80 in pre-market trading. Cowen & Co. upgraded Groupon from Underperform to Market Perform.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Albireo Pharma, Inc. ALBO fell 11.1 percent to $24.00 in pre-market trading after surging 12.51 percent on Friday.
• Inotek Pharmaceuticals Corp ITEK shares fell 8.8 percent to $2.50 in pre-market trading. Inotek Pharmaceuticals declined 7.12 percent Friday after the company reported filing of preliminary proxy statement for a deal with Rocket Pharma.
• ITUS Corp ITUS fell 7.2 percent to $2.96 in pre-market trading after declining 6.45 percent on Friday.
• Athersys, Inc. ATHX fell 5.5 percent to $2.05 in the pre-market trading session as the company disclosed that it entered into agreement with Garnet on October 12, 2017 to settle longstanding intellectual property disagreements.
• Foresight Autonomous Holdings Ltd. FRSX fell 5.2 percent to $6.76 in pre-market trading after climbing 6.74 percent on Friday.
• Riot Blockchain Inc BIOP shares fell 5.1 percent to $7.50 in pre-market trading after slipping 3.66 percent on Friday.
• Antares Pharma Inc ATRS shares fell 4.8 percent to $2.21 in pre-market trading after tumbling 37.80 percent on Friday.
• Arrowhead Pharmaceuticals Inc NASDAQ: ARWR) fell 4.8 percent to $3.81 in pre-market trading after declining 1.48 percent on Friday.
• TG Therapeutics Inc TGTX fell 4.6 percent to $10.50 in pre-market trading. The FDA stated that GENUINE 3 results will cause an issue for getting an accelerated approval.
• Cerus Corporation CERS shares fell 3.6 percent to $3.00 in pre-market trading after declining 1.89 percent on Friday.
• John Bean Technologies Corp JBT fell 2.7 percent to $101.00 in pre-market trading after rising 3.65 percent on Friday.